Annual Retreat 2023
Houston Houston, TX, United StatesIBCG RETREAT 2023The annual International Bladder Cancer Group Retreat was held in Houston, Texas from August 25-26,2023. The meeting was co-chaired by Drs. Shilpa Gupta, Roger Li and Patrick Hensley and convened 60international bladder cancer clinicians, scientists, and patient advocates, including IBCG representationfrom 10 countries. This year’s keynote speaker was Ms. Toby Shor, a bladder cancer survivor andphilanthropist, who remarked on her personal journey from diagnosis through treatment.The 2023 Retreat mission was to generate consensus statements on two disease processes and employeda system of literature review and expert opinion-based recommendation statements with pre-meetingvoting from IBCG membership. Recommendations were revised based on discussion, and final statementsunderwent live voting at the conclusion of the meeting, with ratification of statements achieving consensus.Publication of these proceedings are forthcoming.In the first session, titled “BCG Unresponsive Disease: Recommendations for Optimal Sequencing & PatientSelection for Agents”, the group defined existing and emerging therapeutic strategies for BCG unresponsivenonmuscle-invasive bladder cancer. The adoption of the BCG unresponsive definition by the IBCG and FDAhas been instrumental in patient risk-stratification, insightful interpretation of retrospective clinicaloutcomes, and stimulating the development and evaluation of novel bladder-preserving therapies throughclinical trials. The following topics were discussed:Chemotherapy-Based TreatmentsImmunotherapy/Checkpoint InhibitorsGene Therapy-Based AgentsImmunotherapy-Based AgentsTargeted & Miscellaneous TreatmentsBiomarkers for […]